Hagen Rachael, Nguyen Minh Thu T, Anderson Joseph C, Birk John W
Department of Medicine.
Division of Gastroenterology and Hepatology, Department of Medicine, University of Connecticut Health Center, Farmington, CT.
J Clin Gastroenterol. 2025 Apr 1;59(4):285-297. doi: 10.1097/MCG.0000000000002124.
Colorectal cancer (CRC) is the third most common cancer in the United States. Early detection through colonoscopy significantly improves survival rates. Detecting colon polyps depends on the quality of bowel preparation. However, inadequate bowel preparation remains a significant issue in clinical practice. Efforts to address this challenge have led to the development of bowel preparation regimens emphasizing efficacy, tolerability, and safety. Bowel preparation options can be categorized by their osmotic and volume properties. Isosmotic solutions based on polyethylene glycol-electrolyte lavage solutions (PEG-ELS) are available in both low-volume PEG-ELS with ascorbic acid (PEG-Asc) (e.g., MoviPrep, PLENVU) and high-volume formulations (e.g., GoLYTELY, CoLyte), as well as sulfate-free high-volume PEG-ELS formulations (SF-PEG-ELS). Hyperosmotic solutions include oral sulfate solution (OSS) (e.g., SUPREP), sodium phosphate tablets (NaP) (e.g., OsmoPrep), oral sulfate tablets (OST) (e.g., SUTAB), flavored PEG with sulfate salts (FPSS) (e.g., SUFLAVE), and magnesium citrate. Hypoosmotic solutions consist of PEG-sports drink (PEG-SD). In addition, combination solutions are available, such as sodium picosulfate with magnesium citrate (SPMC) with laxatives (e.g., CLENPIQ), and OSS with SF-PEG-ELS (Suclear). Each regimen differs in terms of cost, volume, taste, contraindications, and potential adverse effects. Therefore, clinicians must carefully evaluate each patient to determine the most suitable regimen for their patients.
结直肠癌(CRC)是美国第三大常见癌症。通过结肠镜检查进行早期检测可显著提高生存率。结肠息肉的检测取决于肠道准备的质量。然而,肠道准备不充分在临床实践中仍然是一个重大问题。应对这一挑战的努力促使了强调有效性、耐受性和安全性的肠道准备方案的发展。肠道准备方案可根据其渗透和容量特性进行分类。基于聚乙二醇电解质灌洗液(PEG-ELS)的等渗溶液有低容量含抗坏血酸的PEG-ELS(PEG-Asc)(如MoviPrep、PLENVU)和高容量制剂(如GoLYTELY、CoLyte),以及无硫酸盐高容量PEG-ELS制剂(SF-PEG-ELS)。高渗溶液包括口服硫酸盐溶液(OSS)(如SUPREP)、磷酸钠片(NaP)(如OsmoPrep)、口服硫酸片剂(OST)(如SUTAB)、含硫酸盐的调味PEG(FPSS)(如SUFLAVE)和枸橼酸镁。低渗溶液由PEG运动饮料(PEG-SD)组成。此外,还有联合溶液,如匹可硫酸钠与枸橼酸镁(SPMC)加泻药(如CLENPIQ),以及OSS与SF-PEG-ELS(Suclear)。每种方案在成本、容量、味道、禁忌症和潜在不良反应方面都有所不同。因此,临床医生必须仔细评估每位患者,以确定最适合其患者的方案。